Basic Study
Copyright ©The Author(s) 2016.
World J Gastroenterol. Jul 21, 2016; 22(27): 6235-6245
Published online Jul 21, 2016. doi: 10.3748/wjg.v22.i27.6235
Figure 4
Figure 4 Down-regulation of activating transcription factor 4 significantly reverses the glucose deprivation-induced resistance of HCT116 cells to chemotherapy. A: Silencing ATF4 expression using shATF4 in GD-treated LoVo and HCT116 cells; B: Depletion of ATF4 enhanced the sensitivity of HCT116 cells to LOHP and 5-FU. The in vitro drug sensitivity was tested using the CCK-8 assay. aP < 0.05, bP < 0.01, cP < 0.001, control vs GD. GD: Glucose deprivation.